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regions would be conserved differ-
ently must be considered.
It is probable that subsequent 
sequences of HGyVs remain to be 
identified in human blood. A recent 
study reported the characterization 
of a highly divergent GyV sequence 
(GyV4) in human fecal samples and 
chicken meat (7); as with avian GyV2 
and GyV3, further research is needed 
to determine whether this variant rep-
licates in the human body or is solely 
ingested in food and passively excret-
ed. A better knowledge of the genetic 
diversity of these newly discovered 
viruses will enable development of 
improved molecular detection sys-
tems and their subsequent use in epi-
demiologic studies involving diverse 
human cohorts.
The potential clinical importance 
of HGyVs remains to be clarified. Al-
though infection with CAV in birds 
is frequently associated with clini-
cal signs and disease, the presence of 
HGyVs in immunocompromised or 
immunocompetent humans does not 
appear to be correlated with visible 
symptoms. Further studies of the natu-
ral history and distribution of HGyVs 
in human hosts are needed.
Philippe Biagini,  
Sandra Bédarida,  
Mhammed Touinssi,  








  1. Schat KA. Chicken anemia virus. Curr 
Top Microbiol Immunol. 2009;331:151–
83. http://dx.doi.org/10.1007/978-3-540-
70972-5_10
  2. Sauvage V, Cheval J, Foulongne V, Ar 
Gouilh M, Pariente K, Manuguerra JC, 
et al. Identification of the first human gy-
rovirus, a virus related to chicken anemia 
virus. J Virol. 2011;85:7948–50. http://
dx.doi.org/10.1128/JVI.00639-11
  3. Rijsewijk FA, dos Santos HF, Teixeira 
TF, Cibulski SP, Varela AP, Dezen D, et 
al. Discovery of a genome of a distant 
relative of chicken anemia virus reveals a 
new member of the genus Gyrovirus. Arch 
Virol. 2011;156:1097–100. http://dx.doi.
org/10.1007/s00705-011-0971-6
  4. Phan TG, Li L, O’Ryan MG, Cortes H, 
Mamani N, Bonkoungou IJ, et al. A third 
gyrovirus species in human faeces. J Gen 
Virol. 2012;93:1356–61. http://dx.doi.
org/10.1099/vir.0.041731-0
  5. Maggi F, Macera L, Focosi D, Vatteroni 
ML, Boggi U, Antonelli G, et al. Human 
gyrovirus DNA in human blood, Italy. 
Emerg Infect Dis. 2012;18:956–9. http://
dx.doi.org/10.3201/eid1806.120179
  6. Biagini P, Dussol B, Touinssi M, Brunet P, 
Picard C, Moal V, et al. Human parvovi-
rus 4 in kidney transplant patients, France. 
Emerg Infect Dis. 2008;14:1811–2. http://
dx.doi.org/10.3201/eid1411.080862
  7. Chu DK, Poon LL, Chiu SS, Chan 
KH, Ng EM, Bauer I, et al. Charac-
terization of a novel gyrovirus in hu-
man stool and chicken meat. J Clin 
Virol. 2012;55:209–13. http://dx.doi.
org/10.1016/j.jcv.2012.07.001
Address for correspondence: Philippe Biagini, 
UMR CNRS 7268 Equipe “Emergence et co-
évolution virale,” Etablissement Français du Sang 
Alpes-Méditerranée et Aix-Marseille Université, 
27 Boulevard Jean Moulin, 13005 Marseille, 
France; email: philippe.biagini@efs.sante.fr
Vibrio cholerae  




To the Editor: Vibrio cholerae 
O1, a causative agent of cholera, was 
classified into 2 biotypes, classical and 
El Tor (1). However, accumulating 
evidence suggests that atypical El Tor 
V. cholerae, which possesses traits of 
both classical and El Tor biotypes, has 
replaced the seventh pandemic pro-
totypic El Tor V. cholerae worldwide 
in recent years. Cholera outbreaks 
in Thailand during 2007–2010 were 
caused by atypical El Tor isolates car-
rying the classical type cholera toxin 
gene (2). Epidemiologic surveys in a 
Thailand–Myanmar border area during 
2008–2012 yielded more than 500 iso-
lates of V. cholerae O1. We identified 
an isolate that possessed the typical El 
Tor type cholera toxin gene (genotype 
3) and designated it MS6 (later as-
signed strain number DMST28216). It 
does not belong to either the seventh 
pandemic prototypic biotype identified 
in 1961 or the group of atypical El Tor 
strains found during 1991–present (3).
MS6 was isolated from stool 
samples from a 26-year-old woman 
(migrant worker) from Myanmar who 
had been admitted to Mae Sot General 
Hospital in Tak Province, Thailand, 
for 3 days with vomiting, watery diar-
rhea, nausea, fever, and headache. The 
illness was considered mild to mod-
erate. Acute gastroenteritis was diag-
nosed on the basis of the symptoms 
and laboratory results. The key viru-
lence factors of V. cholerae O1 include 
cholera toxin (CTX), which is respon-
sible for profuse watery diarrhea, and 
a pilus colonization factor known as 
toxin-coregulated pilus (TCP). The 
virulence-related genes (ctxAB and 
tcpA) and the phage repressor gene 
(rstR) of MS6 had identical sequences 
to those of the seventh pandemic pro-
totypic El Tor V. cholerae O1 N16961 
strain. The isolate was found to be 
positive for enteric bacteria in the 
Voges-Proskauer test and resistant to 
polymyxin B (50 units). We further 
investigated 2 gene clusters, Vibrio 
seventh pandemic island I (VSP-I) 
and II (VSP-II), associated with the 
seventh pandemic strains and absent 
in classical and pre–seventh pandemic 
strains (4–7). The common genes on 
the VSP-I island in N16961, including 
VC0175, VC0178, VC0180, VC0181, 
and VC0183, were detected by PCR 
(8) in MS6 but were lacking in VSP-
II; 26.9 kb of VSP-II was originally 
found in N16961. Moreover, PCR 
analysis showed that the isolate did not 
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	19,	No.	6,	June	2013	 1015
LETTERS
possess the VC2346 gene, a specific 
marker of the seventh pandemic clone 
(5,9). However, we found a VC2346 
homolog with 83.9% sequence identi-
ty with VC2346 at the nucleotide level 
and 97% at the amino acid level in 
the 624-bp region. The coding region 
of the homolog is considered to be 
shorter than VC2346 (684 bp) because 
it contains the stop codon, TAG. This 
homolog was identified in environ-
mental, classical, or pre–seventh pan-
demic strains of V. cholerae O1 (5), 
including MS6, and in 2740–80 (US 
Gulf Coast, 1980), 3569–08 (US Gulf 
Coast, 2008), BX33026 (environmen-
tal water in Australia, 1986), RC27 
(classical, human isolate in Indonesia, 
1991), O395 (classical, human isolate 
in India, 1965), MAK757 and M66–2 
(pre–seventh pandemic, human isolate 
in Indonesia, 1937), and NCTC 8457 
(pre–seventh pandemic, human isolate 
in Saudi Arabia, 1910), excluding sev-
enth pandemic strains. 
This conservation of the homo-
logue of VC2346 in strains isolated 
over the course of a century and the 
geographic distribution of the strains 
suggest a notable biologic function 
and a specific marker. In addition, we 
determined the sequences of 15 house-
keeping genes which exhibited se-
quence variations in toxigenic V. chol-
erae (10). The results indicated that by 
comparison, MS6 is closely related to 
the US Gulf clones (Figure). However, 
2 genes, malP and pepN, of MS6 are 
remotely related to them and are novel 
sequence types, based on results of a 
BLAST (http://blast.ncbi.nlm.nih.gov/
Blast.cgi) search. Antimicrobial sus-
ceptibility testing by using the disk dif-
fusion method revealed that MS6 was 
susceptible to chloramphenicol, cipro-
floxacin, gentamicin, sulfamethoxa-
zole/trimethoprim, tetracycline, strep-
tomycin, furazolidone, doxycycline, 
and norfloxacin, and had intermediate 
susceptibility to ampicillin and eryth-
romycin, suggesting that MS6 had not 
been exposed to several antimicrobial 
drugs. The V. cholerae SXT element, 
which usually shows code drug-resis-
tance markers, integrates into a spe-
cific site of the prfC gene. In MS6, 
the complete prfC gene was detected. 
The accession numbers of DDBJ for 
nucleotide sequences determined in 
this study are AB699244-AB699265. 
MS6 possesses unique properties in 
terms of the ribotype, pulsed-field gel 
electrophoresis pattern, and multiple-
locus variable-number tandem-repeat 
analysis profile, compared with other 
V. cholerae O1 isolates (2).
This case was probably an epi-
sode of sporadic cholera from indig-
enous V. cholerae O1, such as US Gulf 
Coast and Australian clones, which are 
mainly associated with environmental 
sources. We have been unable to iso-
late another MS6-like clone, which 
could have escaped detection because 
of low prevalence or might exist in a 
dormant state in a rural area. Never-
theless, the transmission route and its 
pathogenicity must be of concern for 
public health.
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To the Editor: Crimean-Congo 
hemorrhagic fever (CCHF) is a tick-
borne zoonotic disease caused by 
a member of the virus family Bun-
yaviridae, genus Nairovirus. This 
virus (CCHFV) has caused illness 
throughout Asia, Europe, Africa, and 
the Middle East (1). CCHFVs are 
clustered among 7 genotypes (Asia-
1, Asia-2, Euro-1, Euro-2, Africa-1, 
Africa-2, and Africa-3) on the basis of 
genetic variation in the small segment 
(2). These genotypes are well con-
served among their regions of origin; 
however, >1 genotype is prevalent in 
many countries (2). In Pakistan, the 
first CCHF case was reported in 1976; 
multiple sporadic cases and outbreaks 
have occurred in subsequent years (3). 
To determine which genotypes 
were present in Pakistan, we per-
formed molecular analysis of archived 
serum samples collected during 2008 
in Fatima Jinnah General and Chest 
Hospital, Quetta, Baluchistan, in 
southwestern of Pakistan. Because of 
limited diagnostic facilities for CCH-
FV in this country, samples collected 
during 1976–2002 were occasionally 
sent to laboratories in countries such 
as South Africa and the United States, 
where genetic analysis showed that 
all viruses tested from that location 
belonged to the Asia-1 genotype (4). 
Data beyond this period are not avail-
able; however, because of improved 
molecular diagnostic facilities at the 
Department of Virology, National 
Institute of Health, Pakistan, blood 
samples collected from patients with 
suspected cases attending in-country 
hospitals are now examined by the in-
stitute for confirmation. Our findings 
substantiate the presence of Asia-1 
and Asia-2 genotypes in Baluchistan.
Thirteen IgM-positive samples 
collected during 2008 and stored at 
–70°C were available for study. The 
samples were processed for amplifi-
cation of 260 bp of the small segment 
by using reverse transcription PCR 
with a previously described protocol 
(5). The mean age of patients with 
serology-confirmed CCHF was 31.3 
(range 18–40) years; male-to-female 
IgM positivity ratio was 1:2. Com-
mon symptoms were fever, head-
ache, and nosebleeds. Platelet counts 
ranged from 16,000 to 43,000/μL 
of blood. 
Of the 13 samples, viral RNA was 
detected in 2 (CCHF-65–2008PAK 
and CCHF-43–2008PAK); the ampli-
cons were subjected to bidirectional 
sequencing by using the BigDye Ter-
minator v3.1 cycle sequencing kit 
(Applied BioSystems, Foster City, 
CA, USA). Sequences were analyzed 
with Sequencher (GeneCodes Corp., 
Ann Arbor, MI, USA) and MEGA 
v4.0 (http://megasoftware.net/). 
The 2 viruses were phylogenetical-
ly clustered into Asia-1 and Asia-2 
genotypes, with 7% nucleotide di-
vergence, although both samples 
were collected during September–
October, 2008. 
The closest nucleotide iden-
tity (99%–100%) for CCHF-65–
2008PAK was found with the previ-
ously reported Asia-1 strains from 
Pakistan, Afghanistan, and Iran; 
CCHF-43–2008PAK had 96%–97% 
similarity to viruses from Dubai and 
Tajikistan (Figure). The sequences 
reported from United Arab Emir-
ates, Pakistan, Afghanistan, Iran, and 
Iraq belong to the Asia-1 genotype; 
the Asia-2 genotype sequences were 
mostly from China and Central Asian 
countries such as Uzbekistan, Tajiki-
stan, and Kazakhstan (6). All viruses 
detected intermittently in Pakistan 
during 1976–2002 were of the Asia-
1 genotype (4). However, the analy-
sis of the 2 samples reported here 
enhances our knowledge of CCHFV 
genetic diversity in Pakistan. 
The closest phylogenetic posi-
tioning of CCHF-43–2008PAK with 
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